microRNA-802 is involved in palmitate-induced damage to pancreatic β cells through repression of sirtuin 6

Ning Lin1, Yixin Niu1, Weiwei Zhang1

  • 1Department of Endocrinology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China.

Insights

MicroRNA-802 (miR-802) exacerbates free fatty acid damage to pancreatic beta cells, a key factor in type 2 diabetes. Inhibiting miR-802 protects these cells by targeting SIRT6, offering a potential therapeutic strategy for T2DM.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Free fatty acid (FFA) excess contributes to pancreatic beta-cell dysfunction and loss, a hallmark of type 2 diabetes mellitus (T2DM).
  • Elevated circulating microRNA-802 (miR-802) levels are observed in T2DM patients, but its specific role in FFA-induced beta-cell damage remains elusive.

Purpose of the Study:

  • To investigate the role of miR-802 in free fatty acid (palmitate)-induced damage to pancreatic beta cells.
  • To identify the molecular mechanisms and therapeutic potential of targeting miR-802 in the context of T2DM pathogenesis.

Main Methods:

  • Palmitate treatment of INS-1 rat insulinoma cells to induce FFA damage.
  • miR-802 expression analysis, gain- and loss-of-function studies.
  • Assessment of apoptosis, reactive oxygen species (ROS) production, and protein levels (Mcl-1, Bcl-xL, SIRT6).

Main Results:

  • Palmitate treatment increased miR-802 expression in INS-1 cells in a time- and concentration-dependent manner.
  • miR-802 knockdown protected beta cells from palmitate-induced apoptosis and ROS generation, preserving prosurvival proteins.
  • miR-802 directly targets Sirtuin 6 (SIRT6), and its overexpression suppressed SIRT6, leading to increased apoptosis and ROS.

Conclusions:

  • miR-802 is essential for palmitate-induced beta-cell damage by downregulating SIRT6.
  • Targeting miR-802 presents a promising therapeutic avenue for T2DM by protecting pancreatic beta cells from lipotoxicity.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K